The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study

for GUSTA trial study group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e17-e21
JournalJournal of acquired immune deficiency syndromes (1999)
Issue number1
Publication statusPublished - May 1 2019

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this